Factory supply Sunitinib Malate CAS NO.341031-54-7

Min.Order: 10 Gram
Payment Terms: T/T,

Product Details

Keywords

Sunitinib Malate
Sunitinib
cas 341031-54-7

Quick Details

ProName: Factory supply Sunitinib Malate
CasNo: 341031-54-7
Molecular Formula: C22H27FN4O2
Appearance: white powder
Application: is an inhibitor used in the treatment...
DeliveryTime: immediately
PackAge: aluminum foil bag
Port: HK, Shanghai, Shenzhen
ProductionCapacity: 100 Kilogram/Month
Purity: 99%
Storage: cool and dry place
Transportation: email: wonda-chem@outlook.com
LimitNum: 10 Gram

Superiority

1.high quality:

quality is life. quality is the most important element for all goods. we have a lab doing research in wuhan china. hplc and nmr is available if needed.

2.reasonable price:

we provide high quality products with competitive price in china. all customers are welcomed to send us inquiries and get quotation.

3.low moq:

no worry about the low moq, our moq is 1 gram or even lower.

4.good service.

fast response. we promise to reply within 24 hours including holidays and send quotation sheet and other documents within 48 hours.

5. fast shipping and secure courier.

we promise to send out products and provide tracking number within 3 working days. and we send via different couriers based on different destination countries. we usually use nl post, hk post, germany post, eub, etk, etc.

Details

Product Description

Product name : Sunitinib Malate

Appearance: Off white powder

Odor: Characteristic

Grade: Medicine Grade, Tech Grade

Specification: >99%

Usage:For research purposes only

Sunitiba Malate is an antineoplastic agent and a potent RTK inhibitor which includes Flk-1 (VEGFR2) as a primary target. It also is a potent, ATP-competitive inhibitor of VEGFR, PDGFR-β and c-Kit (KIT). Sunitiba Malate inhibits cellular receptor phosphorylation of FLT3, RET and CSF-1R. Exhibits antiangiogenic and antitumor activity in multiple xenograft models. Sunitinib Malate is an inhibitor of c-Fms-CSF-1R, Flt-1, Flt-3/Flk-2, Flt-4, PDGFR-α and Ret.

Functions

Sunitinib Malate has very good oral bioavailability, is highly efficacious

in a number of preclinical tumor models, and is well tolerated at efficacious doses.

Sunitinib malate is an inhibitor used in the treatment of advanced renal cell carcinoma

and gastrointestinal stromal tumors.